IGKV6D-21 and central nervous system cancer: Immunolabeling of human glioma tissue samples with antibodies directed against integrin subunit α10 demonstrated a broad distribution and distinct cellular expression of integrin α10β1 in high-grade gliomas (astrocytoma grade III and GBM) (Figure 1A).